Thrombopoietin protects mice from mortality and myelosuppression following high-dose irradiation: Importance of time scheduling

Canadian Journal of Physiology and Pharmacology

Volumn 80, Issue 7, 2002, Pages 717-721

  Mouthon, Marc André ^a,b   Van der Meeren, Anne ^a   Vandamme, Marie ^a   Squiban, Claire ^a   Gaugler, Marie Hélène ^a  

^a INSTITUT DE RADIOPROTECTION ET DE SÛRETÉ NUCLÉAIRE   (France)

^b Sect Autonome Radiobiol Appl Med   (France)

Author keywords

Hematopoiesis; Irradiation; Survival; Thrombopoietin

Indexed keywords

PLACEBO; THROMBOPOIETIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BLOOD CELL COUNT; BONE MARROW; BONE MARROW SUPPRESSION; CELL SURVIVAL; CHO CELL; CONFERENCE PAPER; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG SCREENING; HEMATOPOIESIS; MALE; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; RADIATION DOSE; STEM CELL; THROMBOCYTOPOIESIS;

ANIMALS; BLOOD CELL COUNT; DOSE-RESPONSE RELATIONSHIP, DRUG; GRANULOCYTES; HEMATOPOIESIS; HEMATOPOIETIC STEM CELLS; MALE; MICE; MICE, INBRED C57BL; RADIATION INJURIES, EXPERIMENTAL; SURVIVAL ANALYSIS; THROMBOPOIETIN; TIME FACTORS;

EID: 0036446873     PISSN: 00084212     EISSN: None     Source Type: Journal    
DOI: 10.1139/y02-090     Document Type: Conference Paper

References (11)

1. Borge, O.J., Ramsfjell, V., Cui, L., and Jacobsen, S.E. 1997. Ability of early acting cytokines to directly promote survival and suppress apoptosis of human primitive CD34+CD38- bone marrow cells with multilineage potential at the single-cell level: Key role of thrombopoietin. Blood, 90: 2282-2292.
2. Drouet, M., Mathieu, J., Grenier, N., Multon, E., Sotto, J.J., and Herodin, F. 1999. The reduction of in vitro radiation-induced Fas-related apoptosis in CD34+ progenitor cells by SCF, FLT-3 ligand, TPO, and IL-3 in combination resulted in CD34+ cell proliferation and differentiation. Stem Cells, 17: 273-285.
3. Eaton, D.L., and de Sauvage, F.J. 1997. Thrombopoietin: The primary regulator of megakaryocytopoiesis and thrombopoiesis. Exp. Hematol. 25: 1-7.
4. Farese, A.M., Hunt, P., Grab, L.B., and MacVittie, T.J. 1996. Combined administration of recombinant human megakaryocyte growth and development factor and granulocyte colony-stimulating factor enhances multilineage hematopoietic reconstitution in nonhuman primates after radiation-induced marrow aplasia. J. Clin. Invest. 97: 2145-2151.
5. Hokom, M.M., Lacey, D., Kinstler, O.B., Choi, E., Kaufman, S., Faust, J., Rowan, C., Dwyer, E., Nichol, J.L., Grasel, T., Wilson, J., Steinbrink, R., Hecht, R., Winters, D., Boone, T., and Hunt, P. 1995. Pegylated megakaryocyte growth and development factor abrogates the lethal thrombocytopenia associated with carboplatin and irradiation in mice. Blood, 86: 4486-4492.
6. Mouthon, M.A., Van der Meeren, A., Gaugler, M.H., Visser, T.P., Squiban, C., Gourmelon, P., and Wagemaker, G. 1999. Thrombopoietin promotes hematopoietic recovery and survival after high-dose whole body irradiation. Int. J. Radiat. Oncol. Biol. Phys. 43: 867-875.
7. Mouthon, M., Gaugler, M., Van der Meeren, A., Vandamme, M., Gourmelon, P., and Wagemaker, G. 2001. Single administration of thrombopoietin to lethally irradiated mice prevents the infectious and thrombotic events leading to mortality. Exp. Hematol. 29: 30-40.
8. Neelis, K.J., Visser, T.P., Dimjati, W., Thomas, G.R., Fielder, P.J., Bloedow, D., Eaton, D.L., and Wagemaker, G. 1998. A single dose of thrombopoietin early after myelosuppressive total body irradiation prevents pancytopenia by promoting short-term multilineage repopulating cells at the expense of a more immature cell population. Blood, 92: 1586-1597.
9. Shibuya, K., Akahori, H., Takahashi, K., Tahara, E., Kato, T., and Miyazaki, H. 1998. Multilineage hematopoietic recovery by a single injection of pegylated recombinant human megakaryocyte growth and development factor in myelosuppressed mice. Blood, 91: 37-45.
10. van de Ven, C., Fernandez, G.W., Herbst, T., Knoppel, A., Kulczyk, S.T., and Cairo, M.S. 1998. The haemopoietic effects of thrombopoietin administered post-myelosuppressive carboplatin therapy compared to either pre- and post- or pre-chemotherapy. Br. J. Haematol. 102: 775-782.
11. Wagemaker, G., Neelis, K.J., Hartong, S.C.C., Wognum, A.W., Thomas, G.R., Fielder, P.J., and Eaton, D.L. 1998. The efficacy of recombinant TPO in murine and nonhuman primate models for myelosuppression and stem cell transplantation. Stem Cells, 16: 127-141.